摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

噌啉-8-胺 | 21905-84-0

中文名称
噌啉-8-胺
中文别名
——
英文名称
Cinnolin-8-amine
英文别名
——
噌啉-8-胺化学式
CAS
21905-84-0
化学式
C8H7N3
mdl
MFCD19203784
分子量
145.16
InChiKey
RSGJRKSGEFJCKO-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.5
  • 重原子数:
    11
  • 可旋转键数:
    0
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    51.8
  • 氢给体数:
    1
  • 氢受体数:
    3

文献信息

  • [EN] HERBICIDAL CINNOLINIUM COMPOUNDS<br/>[FR] COMPOSÉS HERBICIDES À BASE DE CINNOLINIUM
    申请人:SYNGENTA CROP PROTECTION AG
    公开号:WO2020127168A1
    公开(公告)日:2020-06-25
    Compounds of the formula (I) wherein the substituents are as defined in claim 1, useful as a pesticides, especially as herbicides.
    式(I)中的化合物,其中取代基如权利要求1中定义的那样,作为杀虫剂特别是除草剂是有用的。
  • [EN] TRICYCLIC BENZOPYRAN COMPOUND AS ANTI-ARRHYTHMIC AGENTS<br/>[FR] COMPOSE DE BENZOPYRANNE TRICYCLIQUE EN TANT QU'AGENTS ANTI-ARRYTHMIQUES
    申请人:NISSAN CHEMICAL IND LTD
    公开号:WO2005090357A1
    公开(公告)日:2005-09-29
    This invention relates to benzopyran derivatives of formula (I) or (II), or pharmaceutically acceptable salts thereof wherein R1 and R2 are independently of each other hydrogen atom, C1-6alkyl group or C6-14aryl group, R3 is hydrogen atom or C1-6alkylcarbonyloxy group, or together with R4 forms a bond, R4 is hydrogen atom, or together with R3 forms a bond, m is an integer of 0 to 4, n is an integer of 0 to 4, V is a single bond, CR7R8, NR9, O, S, SO or SO2, R5 is hydrogen atom or C1-6alkyl group, R6 is hydrogen atom, C1-6alkyl group, C3-8cycloalkyl group, C3-8cycloalkenyl group, amino group, C1-6alkylamino group, di-C1-6alkylamino group, C6-14arylamino group, C2-9heteroarylamino group, C6-14aryl group, C2-9heteroaryl group or C2-9heterocyclyl group, A is 5-, 6- or 7-member ring fused with benzene ring, as constituent atom of the ring, oxygen atom, nitrogen atom or sulfur atom may be contained in the number of 1 to 3 alone or in a combination thereof, the number of unsaturated bond in the ring is 1, 2 or 3 including an unsaturated bond of the benzene ring to be fused, carbon atoms constituting the ring may be carbonyl or thiocarbonyl. These compounds are useful as an anti-arrhythmic agent.
    本发明涉及公式(I)或(II)的苯并吡喁衍生物,或其药学上可接受的盐,其中R1和R2分别是氢原子、C1-6烷基或C6-14芳基,R3是氢原子或C1-6烷基羰氧基,或与R4一起形成键,R4是氢原子,或与R3一起形成键,m是0到4的整数,n是0到4的整数,V是单键,CR7R8,NR9,O,S,SO或SO2,R5是氢原子或C1-6烷基,R6是氢原子,C1-6烷基,C3-8环烷基,C3-8环烯基,氨基,C1-6烷基氨基,二C1-6烷基氨基,C6-14芳基氨基,C2-9杂芳基氨基,C6-14芳基,C2-9杂芳基或C2-9杂环烷基,A是与苯环融合的5、6或7成员环,作为环的组成原子,氧原子、氮原子或硫原子可以单独或组合地包含在其中,环中的不饱和键数为1、2或3,包括与苯环融合的不饱和键,构成环的碳原子可以是羰基或硫代羰基。这些化合物可用作抗心律失常药物。
  • NANOPORE BASED SEQUENCER
    申请人:ARIZONA BOARD OF REGENTS on behalf of ARIZONA STATE UNIVERSITY
    公开号:US20170204066A1
    公开(公告)日:2017-07-20
    The present invention is directed to systems, devices and methods for identifying biopolymers, such as strands of DNA, as they pass through a constriction such as a carbon nanotube nanopore. More particularly, the invention is directed to such systems, devices and methods in which a newly translocated portion of the biopolymer forms a temporary electrical circuit between the nanotube nanopore and a second electrode, which may also be a nanotube. Further, the invention is directed to such systems, devices and methods in which the constriction is provided with a functionalized unit which, together with a newly translocated portion of the biopolymer, forms a temporary electrical circuit that can be used to characterize that portion of the biopolymer.
    本发明涉及用于识别生物聚合物(例如DNA链)的系统、设备和方法,当它们通过像碳纳米管纳孔这样的狭窄通道时。更具体地说,本发明涉及这种系统、设备和方法,其中生物聚合物的新穿过部分在纳米管纳孔和第二电极之间形成临时电路,第二电极也可能是一个纳米管。此外,本发明涉及这种系统、设备和方法,其中通道配备有一个功能化单元,该单元与生物聚合物的新穿过部分一起形成临时电路,可用于表征生物聚合物的部分。
  • Process for Producing Optically Active Chromene Oxide Compound
    申请人:Kondo Shoichi
    公开号:US20090043100A1
    公开(公告)日:2009-02-12
    [Problems] To provide an efficient process for producing an optically active chromene oxide compound which is an important intermediate for a benzopyran compound effective in the treatment of arrhythmia. [Means For Solving Problems] The process for producing an optically active chromene oxide compound comprises using an optically active titanium complex represented by, e.g., the formula (1) or (2) as a catalyst to asymmetrically oxidize an optically active chromene compound with high enantioselectivity in high chemical yield.
    [问题] 提供一种高效的生产光学活性的色兰氧化合物的方法,该化合物是治疗心律失常的苯并吡喃化合物的重要中间体。 [解决问题的方法] 生产光学活性的色兰氧化合物的方法包括使用光学活性钛配合物作为催化剂,例如使用公式(1)或(2)表示的光学活性钛配合物,以高对映选择性和高化学收率不对称氧化光学活性的色兰化合物。
  • Tricyclic Benzopyrane Compound as Anti-Arrhythmic Agents
    申请人:Ohrai Kazuhiko
    公开号:US20080004262A1
    公开(公告)日:2008-01-03
    This invention relates to benzopyran derivatives of formula (I) or (II), or pharmaceutically acceptable salts thereof wherein R 1 and R 2 are independently of each other hydrogen atom, C 1-6 alkyl group or C 6-14 aryl group, R 3 is hydrogen atom or C 1-6 alkylcarbonyloxy group, or together with R 4 forms a bond, R 4 is hydrogen atom, or together with R 3 forms a bond, m is an integer of 0 to 4, n is an integer of 0 to 4, V is a single bond, CR 7 R 8 , NR 9 , O, S, SO or SO 2 , R 5 is hydrogen atom or C 1-6 alkyl group, R 6 is hydrogen atom, C 1-6 alkyl group, C 3-8 cycloalkyl group, C 3-8 cycloalkenyl group, amino group, C 1-6 alkylamino group, di-C 1-6 alkylamino group, C 6-14 arylamino group, C 2-9 heteroarylamino group, C 6-14 aryl group, C 2-9 heteroaryl group or C 2-9 heterocyclyl group, A is 5-, 6- or 7-member ring fused with benzene ring, as constituent atom of the ring, oxygen atom, nitrogen atom or sulfur atom may be contained in the number of 1 to 3 alone or in a combination thereof, the number of unsaturated bond in the ring is 1, 2 or 3 including an unsaturated bond of the benzene ring to be fused, carbon atoms constituting the ring may be carbonyl or thiocarbonyl. These compounds are useful as an anti-arrhythmic agent.
    本发明涉及式(I)或(II)的苯并吡喃衍生物,或其药学上可接受的盐,其中R1和R2独立地为氢原子,C1-6烷基或C6-14芳基;R3为氢原子或C1-6烷基羰氧基,或与R4一起形成键;R4为氢原子,或与R3一起形成键;m为0至4的整数,n为0至4的整数,V为单键,CR7R8,NR9,O,S,SO或SO2;R5为氢原子或C1-6烷基,R6为氢原子,C1-6烷基,C3-8环烷基,C3-8环烯基,氨基,C1-6烷基氨基,二C1-6烷基氨基,C6-14芳基氨基,C2-9杂芳基氨基,C6-14芳基,C2-9杂芳基或C2-9杂环烷基;A为与苯环融合的5、6或7元环,作为环的组成原子,其中单独或组合存在1至3个氧原子、氮原子或硫原子,环中不饱和键的数量为1、2或3,包括与苯环融合的不饱和键,构成环的碳原子可以是羰基或硫代羰基。这些化合物可用作抗心律失常药物。
查看更多